Skip to main content
Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4506 ISIN · JP3495000006 LEI · 529900D60UKVYLJ2OJ79 T Manufacturing
Filings indexed 94 across all filing types
Latest filing 2020-06-23 Annual Report
Country JP Japan
Listing T 4506

About Sumitomo Pharma Co., Ltd.

https://www.sumitomo-pharma.com/

Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.

Recent filings

Filing Released Lang Actions
有価証券報告書-第200期(平成31年4月1日-令和2年3月31日)
Annual Report
2020-06-23 Japanese
四半期報告書-第200期第3四半期(令和1年10月1日-令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis (MDA), and segment performance data for the third quarter of the 200th fiscal period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-02-05 Japanese
四半期報告書-第200期第2四半期(2019/07/01-2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and segment performance data for the second quarter of the fiscal year ending March 2020. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2020
2019-11-01 Japanese
四半期報告書-第200期第1四半期(2019/04/01-2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and business performance data for the first quarter of the 200th fiscal period (April 1, 2019, to June 30, 2019). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-08-05 Japanese
有価証券報告書-第199期(平成30年4月1日-平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the fiscal year ending March 31, 2019, for Sumitomo Dainippon Pharma Co., Ltd., and includes XBRL-style tagging for financial statements and segment reporting. It is a comprehensive annual filing, not an announcement or a summary. FY 2019
2019-06-20 Japanese
四半期報告書-第199期第3四半期(2018/10/01-2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis, and business updates for the third quarter of the 199th fiscal period (April 1, 2018 to December 31, 2018). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements, it is classified as an Interim/Quarterly Report. 9M 2019
2019-02-01 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.